Multi-arm trial of Inflammatory Signal Inhibitors for COVID-19 (MATIS)

Registry ID

EUCTR2020-001750-22

Source registry

EUCTR

Status

GB - no longer in EU/EEA

Phase

PHASE2

Sponsor

Joint Research Compliance Office

Start date

2020-07-09

Last update

2026-08-16

Conditions

• COVID-19 pneumonia

Summary

• Determine the efficacy of RUX and FOS to reduce the proportion of hospitalised patients progressing from mild to severe COVID-19 pneumonia

Locations

• , , UK

View on source registry